Complexo Hospitalario Universitario De Vigo — Clinical Trial Site

93 Registered trials

39 Currently recruiting

Organisation

Complexo Hospitalario Universitario De Vigo

Location

Vigo, Spain

Identifier

ORG-100042402

Address

Estrada Clara Campoamor N 341, 36312, Spain

Departments

#2249; Reumatología
#3405 - Reumatología
#40099: Reumatología
#40099:Reumatología
#7008:Reumatología
#ES10005:Aparato Digestivo
1410: Reumatologia
2249: Reumatologia
2607:Oncology
3405: Reumatología
4253:Reumatologia
7009: Oncología Médica
7509 Rheumatology
Alergología
Anesthesiology
Cardiología
Cardiology
Cardiology department
Cardiology Service
Departamento de Neurología
ES10001: Aparato Digestivo
ES10010: Gastroenterology
Gastroenterology
Hematology
Hospital Alvaro Cunqueiro - Servicio de Oncologia
Infectious Disease Department
infectious diseases
Internal Medicine
Medical Oncology
N/A
Neurología
Neurology
Oncología
Oncología Radioterápica
Oncology
Oncology Service
Pediatric
Pediatric oncology
Physical Medicine and Rehabilitatio. Hospital Meixoeiro; Rua do Meixoeiro, S/N, Vigo
Preventive Medicine
Psiquiatría
Psychiatry
Reumatologia
Rheumatology
Rheumatology – Hospital Do Meixoeiro
Rheumatology service
Servicio de Cardiologia
Servicio de Medicina Interna, Unidad de infecciosas
Servicio de Neumología
Servicio de neurología
Servicio de Psiquiatría
Servicio de Reumatología
Servico de Reumatologia
Surgery
UCG Medicina Interna
Unidad del Dolor

Clinical trials at this site (93)

Search interface

Beta-Blockers in Takotsubo Syndrome: A Randomized Clinical Trial Recruiting

2023-510213-25-01 Takotsubo Syndrome (TT) is an acute cardiac condition 6 2024-07-08
A study of the efficacy and safety of belimumab compared to placebo in adults with systemic sclerosis-associated interstitial lung disease. Recruiting

2023-503219-14-01 systemic sclerosis associated interstitial lung disease 10 2024-05-22
Phase 3 extension study to evaluate long-term safety of two regimens of ianalumab in participants with systemic lupus erythematosus (SIRIUS-… Recruiting

2023-505929-14-00 Systemic Lupus Erythematosus 5 2024-05-21
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
A study to Evaluate Efficacy and Safety of Giredestrant Compared with Fulvestrant (plus a CDK4/6 inhibitor), in Participants with ER+ HER2-N… Recruiting

2022-502980-39-00 Estrogen receptor (ER)-positive, HER2-negative advanced 5 2024-01-25
A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab… Recruiting

2023-503224-66-00 Atrial Fibrillation 5 2023-10-31
A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic inflammat… Recruiting

2022-502851-79-00 Active Idiopathic Inflammatory Myopathy (IIM) 5 2023-09-20
Clinical trial of androgen deprivation therapy combined with salvage radiotherapy when treating prostate cancer that has suffered recurrence… Recruiting

2024-517666-41-00 Prostate Cancer 5 2023-03-13
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo… Recruiting

2023-508963-58-00 Symptomatic hypertrophic cardiomyopathy (HCM) 4 2022-01-31
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLU… Recruiting

2023-507372-42-00 Schizophrenia 4 2021-09-20
Roll Over Study for Patients Who Have Completed a Previous Oncology Study with Olaparib Recruiting

2024-512982-15-00 BRCA Mutated Ovarian Cancer Patients, Epithelian ovaria 5 2021-06-28
A study investigating single injection of new botulinum toxin to determine safety and efficacy for treating spasticity in the upper limb Recruiting

2023-507202-14-00 Upper limb spasticity after stroke or traumatic brain i 7 2021-04-29
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES Recruiting

2022-502706-33-00 Patients with invasive breast cancer in early stages 6 2018-01-10
Efficacy and safety study of frexalimab (SAR441344) in adults with nonrelapsing secondary progressive multiple sclerosis Ended

2023-504359-29-01 Multiple sclerosis 5 2024-12-11
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis Ended

2024-514343-29-00 multiple sclerosis 5 2024-11-19
Transmural Healing and Disease Modifying Effect of Guselkumab in Crohn’s Disease Patients Ended

2023-504040-34-01 Crohn’s Disease 5 2024-11-12
A Phase III study to investigate the efficacy and safety of anifrolumab in adults with chronic and/or subacute cutaneous lupus erythematosus Ended

2023-503692-24-00 Cutaneous Lupus Erythematosus 5 2024-09-25
Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ended

2023-508456-18-00 Uncomplicated bacteremia caused by E. faecalis or E. fa 6 2024-04-29
An international prospective open-label, multi-center, randomized, non-comparative phase II study of lutetium [177Lu] vipivotide tetraxetan … Ended

2022-503040-41-00 PSMA PET scan positive Castration-Resistant Prostate Ca 4 2024-02-09
Determine effectiveness of Anifrolumab In Systemic sclerosis Ended

2023-505976-31-00 Systemic Sclerosis (SSc) presenting with Limited or Dif 5 2023-11-24
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic … Ended

2023-503655-10-00 Systemic Lupus Erythematosus (SLE). 5 2023-11-20